Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer

T. Andre; C. Sposetti; M. Gumus; J. Bae Ahn; L. Wyrwicz; M. Kwiatkowski; J. Kim; S. Yalcin; M. Sendur; A. Odeleye-Ajakaye; P. Leconte; D. Fogelman; T. Kim

doi:10.1016/j.annonc.2022.04.118

Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer

T. Andre
, C. Sposetti
, M. Gumus
, J. Bae Ahn
, L. Wyrwicz
, M. Kwiatkowski
, J. Kim
, S. Yalcin
, M. Sendur
, A. Odeleye-Ajakaye
, P. Leconte
, D. Fogelman
, T. Kim

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S256-S257
Number of pages	2
Journal	Annals of Oncology
Volume	33
DOIs	https://doi.org/10.1016/j.annonc.2022.04.118
Publication status	Published - Jun 2022
Event	ESMO 24th World Congress on Gastrointestinal Cancer - Barcelona, Spain Duration: 29 Jun 2022 → 2 Jul 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.annonc.2022.04.118

Cite this

Andre, T., Sposetti, C., Gumus, M., Ahn, J. B., Wyrwicz, L., Kwiatkowski, M., Kim, J., Yalcin, S., Sendur, M., Odeleye-Ajakaye, A., Leconte, P., Fogelman, D., & Kim, T. (2022). Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer. Annals of Oncology, 33, S256-S257. https://doi.org/10.1016/j.annonc.2022.04.118

@article{b36d5de2cef34029b20743ee65029375,

title = "Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer",

author = "T. Andre and C. Sposetti and M. Gumus and Ahn, \{J. Bae\} and L. Wyrwicz and M. Kwiatkowski and J. Kim and S. Yalcin and M. Sendur and A. Odeleye-Ajakaye and P. Leconte and D. Fogelman and T. Kim",

year = "2022",

month = jun,

doi = "10.1016/j.annonc.2022.04.118",

language = "English",

volume = "33",

pages = "S256--S257",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

note = "ESMO 24th World Congress on Gastrointestinal Cancer ; Conference date: 29-06-2022 Through 02-07-2022",

}

Andre, T, Sposetti, C, Gumus, M, Ahn, JB, Wyrwicz, L, Kwiatkowski, M, Kim, J, Yalcin, S, Sendur, M, Odeleye-Ajakaye, A, Leconte, P, Fogelman, D & Kim, T 2022, 'Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer', Annals of Oncology, vol. 33, pp. S256-S257. https://doi.org/10.1016/j.annonc.2022.04.118

TY - JOUR

T1 - Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer

AU - Andre, T.

AU - Sposetti, C.

AU - Gumus, M.

AU - Ahn, J. Bae

AU - Wyrwicz, L.

AU - Kwiatkowski, M.

AU - Kim, J.

AU - Yalcin, S.

AU - Sendur, M.

AU - Odeleye-Ajakaye, A.

AU - Leconte, P.

AU - Fogelman, D.

AU - Kim, T.

PY - 2022/6

Y1 - 2022/6

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000823826500041&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1016/j.annonc.2022.04.118

DO - 10.1016/j.annonc.2022.04.118

M3 - Meeting Abstract

SN - 0923-7534

VL - 33

SP - S256-S257

JO - Annals of Oncology

JF - Annals of Oncology

T2 - ESMO 24th World Congress on Gastrointestinal Cancer

Y2 - 29 June 2022 through 2 July 2022

ER -

Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer

UN SDGs

Access to Document

Other files and links

Cite this